U.S. Markets closed

China Cord Blood (CO) in Focus: Stock Rises 8.6%

Zacks Equity Research

China Cord Blood Corporation (CO) was a big mover last session with its shares rising nearly 9% on the day. The move came on solid volume too with far more shares of changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained nearly 23% in the past one-month time frame.
This provider of umbilical cord blood storage and ancillary services has seen 2 negative estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved lower over the same period. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can last.

China Cord Blood currently holds a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Investors interested in the home health care industry may also consider stocks like Almost Family Inc. (AFAM), Amedisys Inc. (AMED) and HEALTHSOUTH Corp. (HLS). All the three stocks bear a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

CHINA CORD BLOOD CORP (CO): Free Stock Analysis Report

ALMOST FAMILY INC (AFAM): Free Stock Analysis Report

AMEDISYS INC (AMED): Free Stock Analysis Report

HEALTHSOUTH CORP (HLS): Free Stock Analysis Report

Zacks Investment Research